Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 21, 2015
HEV infection in two referral centers in Spain: epidemiology and clinical outcomesSabela Lens, Laura Mensa, Martina Gambato, et al.Journal of Gastroenterology and Hepatology|October 11, 2017
Potential drug-drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practiceElena González-Colominas, María-Carlota Londoño, Rosa M Morillas, et al.Scientific Reports|April 27, 2016
Alteration of the serum microbiome composition in cirrhotic patients with ascitesAlba Santiago, Marta Pozuelo, Maria Poca, et al.Hepatology (Baltimore, Md.)|January 19, 2017
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosisCàndid Villanueva, Isabel Graupera, Carles Aracil, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2020
Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligationAlba Ardevol, Edilmar Alvarado-Tapias, Marta Garcia-Guix, et al.Journal of Hepatology|April 17, 2020
Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosisEdilmar Alvarado-Tapias, Alba Ardevol, Marta Garcia-Guix, et al.Hepatology (Baltimore, Md.)|November 7, 2024
Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized trialEdilmar Alvarado-Tapias, Anna Brujats, Angela Puente, et al.Gastroenterologia Y Hepatologia|November 29, 2015
Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infectionDoroteo Acero Fernández, Rosa Morillas Cunill, María José Ferri Iglesias, et al.Plos One|November 15, 2017
Evolution of acute hepatitis C virus infection in a large European city: Trends and new patternsCésar Garriga, Sandra Manzanares-Laya, Patricia García de Olalla, et al.Journal of Gastroenterology and Hepatology|January 21, 2020
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antiviralsSergio Rodríguez-Tajes, Ángela Domínguez, Jose Antonio Carrión, et al.Pageof 4